Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fondaparinux in Morbidly Obese Volunteers
NCT00436787Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Feb 2007
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of fondaparinux in venous thrombosis, pulmonary embolism (PE), sponsored by University of Pittsburgh. Started Feb 2007; status: completed.
02
Drugs
fondaparinux
03
Conditions
venous thrombosispulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00436787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436787.